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Abstract
The activities of developmentally critical transcription factors are regulated via interactions with cofactors. Such interactions
influence transcription factor activity either directly through protein–protein interactions or indirectly by altering the local
chromatin environment. Using a yeast double-interaction screen, we identified a highly conserved nuclear protein, Akirin, as
a novel cofactor of the key Drosophila melanogaster mesoderm and muscle transcription factor Twist. We find that Akirin
interacts genetically and physically with Twist to facilitate expression of some, but not all, Twist-regulated genes during
embryonic myogenesis. akirin mutant embryos have muscle defects consistent with altered regulation of a subset of Twist-
regulated genes. To regulate transcription, Akirin colocalizes and genetically interacts with subunits of the Brahma SWI/SNF-
class chromatin remodeling complex. Our results suggest that, mechanistically, Akirin mediates a novel connection between
Twist and a chromatin remodeling complex to facilitate changes in the chromatin environment, leading to the optimal
expression of some Twist-regulated genes during Drosophila myogenesis. We propose that this Akirin-mediated link
between transcription factors and the Brahma complex represents a novel paradigm for providing tissue and target
specificity for transcription factor interactions with the chromatin remodeling machinery.
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Introduction
A fundamental question in embryonic development is how
diverse cell lineages are specified, patterned and organized from a
single common progenitor. These processes are governed by
distinct gene expression programs administered by tightly
regulated transcription factor activities during embryonic devel-
opment. One mechanism whereby transcription factor activities
are modulated is through direct interactions with cofactors. In
addition, links between transcription factors and the general
transcription machinery can be indirect, such as the actions of
secondary factors that recruit chromatin remodeling complexes to
modify the local chromatin environment and allow gene
activation. The identification of these secondary effectors and
their in vivo function is critical for understanding the regulation of
transcription factor activity during embryonic development. Such
interactions have significant ramifications for developmental
disorders and diseases such as cancer.
The Twist transcription factor represents an ideal model for
studying the regulation of transcription factor activity throughout
development. Twist is a highly conserved transcription factor that
is a key regulator of many developmental programs during
embryogenesis as well as cancer metastasis [1–3]. In Drosophila
melanogaster, Twist regulates multiple, discrete steps of mesoderm
development, including gastrulation, segregation of populations of
mesodermal cells, establishment and formation of the somatic
musculature, and finally establishment of the adult musculature
[4–7]. To achieve these diverse activities, Twist regulates a large
number of target genes temporally within a discrete lineage
resulting in a diverse array of outputs during mesodermal
development [8]. A key question is how these diverse outputs of
Twist activity during development are achieved.
The varied roles of Twist during different phases of embryonic
development and the large number of Twist-regulated target genes
suggest complex regulation of Twist activity [4,8,9]. Twist activity is
often modulated by interactions with other transcription factors
[10,11]. Twist is a basic Helix-loop-Helix (bHLH) transcription
factor that can homodimerize or heterodimerize, with distinct
activities for each dimer pair. For example, Twist homodimers are
responsible for activating target genes that direct cells to the somatic
myogenic lineage [10]. By contrast, heterodimers between Twist
and another bHLH protein, Daughterless, repress the somatic
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interactions with other transcription regulators that bind closely
linked DNA regulatory elements. One such interaction, with the
NF-kB orthologue Dorsal, produces synergistic rather than
cooperative activation of Dorsal targets during development [12–
14]. Hence, Daughterless and Dorsal are examples of transcription
regulators that physically interact with Twist to modify its output.
Other mechanisms that regulate Twist activity during develop-
ment are less clear. One mechanism whereby transcriptional
activity is indirectly regulated is through the action of chromatin
modifying factors that generate a local chromatin environment
that allows and/or favors the expression of a specific target gene.
The structure of chromatin is modified by two predominant
mechanisms: the marking of nucleosome tails with post-transla-
tional modifications such as acetylation, phosphorylation and
methylation, and the remodeling of the local chromatin environ-
ment via factors that reposition nucleosomes in a local gene
environment [15]. Nucleosome repositioning occurs via the
activity of ATP-dependent chromatin remodeling complexes such
as the Brahma-containing (BRM) complex, the Drosophila ortho-
logue of the yeast SWI/SNF chromatin remodeling complex
[15,16]. Mutations in BRM complex subunits have revealed
essential roles for BRM in such processes as homeotic gene
expression, oogenesis, and cell cycle control [17–22]. Loss-of-
function studies have determined that BRM-regulated chromatin
remodeling activity is required for most RNA Polymerase II-
regulated transcription [23]. Most eukaryotic organisms have two
different compositions of the SWI/SNF complex; in Drosophila,
these complexes are designated the BAP (Osa-containing) and
PBAP (polybromo/Bap180, Bap170 and SAYP-containing) com-
plexes [15,16,24]. Both BAP and PBAP are linked to gene
activation and repression, are present in the same cells, and
perform unique yet cooperative functions during development
[19,24–28]. Both the association of BRM complexes with
transcription factors and BRM complex targeting and regulation
during embryogenesis remain an area of considerable interest.
Moreover, links between BRM complexes, chromatin remodeling
and Twist have not yet been elucidated.
The nuclear protein Akirin was shown to regulate gene
expression in several different transcription pathways, yet its
mechanism of action remained unclear [29,30]. Here we identify
Akirin as a factor that facilitates an interaction between Twist and
the BRM chromatin remodeling complex to promote gene
expression. We find that Akirin interacts both physically and
genetically with Twist at Twist-dependent enhancer regions and
positively regulates expression of Dmef2, a Twist-regulated gene
that is critical for somatic myogenesis during development. As
would be predicted by this interaction, akirin mutant embryos show
a range of somatic muscle phenotypes. Akirin is widely associated
with regions of active transcription. We find that Akirin colocalizes
with subunits of the BRM chromatin remodeling complex on
polytene chromosomes and interacts genetically with core subunits
of the BRM complex during myogenesis. Finally, we verify with
chromatin immunoprecipitation that Twist, Akirin, and a core
subunit of the BRM complex all occupy the Twist-dependent
Dmef2 enhancer. Curiously, Akirin/Twist interactions are not
required at all Twist-dependent enhancers, as evidenced by our
chromatin immunoprecipitation experiments at the eve MHE.
These results suggest that Akirin functions as a BRM accessory
protein that links the BRM chromatin remodeling machinery to
Twist transcription factor activity at a subset of Twist-regulated
enhancers. These results provide a common mechanism by which
Akirin links chromatin remodeling factors to spatiotemporal-
specific gene activation.
Results
Akirin is a conserved Twist-interacting nuclear protein
To identify proteins that interact with Twist, we performed a
yeast double interaction screen [31,32]. Two Twist-regulated
enhancers from the Dmef2 [33] and tinman [34] genes were cloned
upstream of a HIS3 reporter. Yeast strains containing these
enhancer/reporter constructs were first transformed with a Twist
expression vector and then with a 0–6 hr embryonic cDNA library
fused to a Gal4 activation domain. Transformants were positively
scored for cDNAs that activated HIS3 expression at Dmef2, tinman,
or both enhancers in a Twist-dependent manner. We identified 28
cDNAs that activated expression from both enhancers. From this
group, we selected the then-unknown gene CG8580 for further
study. CG8580 was found to require the presence of Twist for
activation of the HIS3 reporter [32].
We initially named CG8580 as bhringi [32], but recent groups
have re-designated this gene and its orthologues as akirin [29,35].
For clarity, we have adopted this nomenclature. The Drosophila
akirin gene encodes a highly conserved 201-residue protein with
orthologues present in over 24 different metazoan genomes [35].
Aside from a predicted nuclear localization sequence, Drosophila
Akirin has no known protein motifs [35]. We raised antibodies
against a peptide sequence found in the N-terminal region of
Drosophila Akirin (Figure S1). Immunofluorescence staining of
embryos at various stages of development showed that Akirin is
ubiquitously expressed and found in the nuclei of all cells of the
developing embryo (Figure S2).
akirin mutants display a range of muscle phenotypes
The somatic muscles of Drosophila embryos are arranged in a
stereotypic, repeated pattern of 30 muscles within each abdominal
hemisegment (Figure 1) [36]. Because Akirin interacted with
Twist, a transcription factor that is essential to the proper
Author Summary
The proper development of the diverse array of cell types
in an organism depends upon the induction and
repression of specific genes at particular times and places.
This gene regulation requires both the activity of tissue-
specific transcriptional regulators and the modulation of
the chromatin environment. To date, a complete picture of
the interplay between these two processes remains
unclear. To address this, we examined the activity of the
evolutionarily conserved transcription factor Twist during
embryogenesis of Drosophila melanogaster. While Twist
has multiple activities and roles during development, a
direct link between Twist and chromatin remodeling is
unknown. We identified a highly conserved protein, Akirin,
as a link between Twist and chromatin remodeling factors.
Akirin is required for optimal expression of a Twist-
dependent target during muscle development via inter-
actions with the Drosophila SWI/SNF chromatin remodel-
ing complex. Interestingly, Akirin is not required for
activation of all Twist-dependent enhancers, suggesting
that Akirin refines Twist activity outputs and that different
Twist-dependent targets have different requirements for
chromatin remodeling during development. Our data
further suggests that Akirin similarly links the SWI/SNF
chromatin remodeling complex with other transcription
factors during development. This work has important
ramifications for understanding both normal development
and diseases such as cancer.
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musculature of akirin mutant embryos, using publicly available and
newly generated akirin alleles (See Materials and Methods and
Figure S3). akirin mutant embryos exhibit a range of somatic body
wall muscle phenotypes. Three classes of defects were observed:
missing muscles, attachment defects, and duplicated muscles
(Figure 1). While these defects were seen easily in the 4 lateral
transverse (LT) muscles, the same classes of defects were detected
in several other muscles, particularly the DT1, DO3, DO4 and
DA3 muscles. Misattached, missing or duplicated muscles were
found in stage 16 (15 h after egg laying (AEL)) akirin
2 homozygous
mutant embryos (46.5%, n=114 embryos), and embryos from
crosses of akirin
2 females with akirin
3 males (67%, n=52 embryos),
or akirin
3 females with akirin
5 (44.7%, n=38 embryos) males
(Table 1). The low penetrance of muscle phenotypes seen in akirin
mutants is likely due to the high degree of maternal loading of
akirin RNA (Figure S3). We attempted to generate akirin maternal/
zygotic mutants by making germline clones using akirin
3 mutants
[37]. However, no akirin
MZ mutant embryos were recovered,
suggesting that Akirin is important for oocyte formation (data not
shown). Therefore, homozygous viable akirin
2 females likely
produce embryos that are more highly sensitized to low levels of
akirin mRNA in the oocyte. Importantly, the missing muscle
phenotype is not due to a failure to properly specify muscle
founder cells, as immunohistochemistry of founder cell identity
proteins, including Slouch, Even-skipped and Kru ¨ppel, did not
show a decrease in the numbers of founder cells in akirin mutants
(Figure S4). Also, in akirin mutant embryos there were no obvious
signs of muscle degeneration or late differentiation defects [38]
(data not shown). Epidermal development was normal, and the
cuticle developed normally (data not shown).
Akirin interacts both genetically and physically with Twist
The muscle phenotypes in akirin mutant embryos were
reminiscent of those observed in embryos in which twist expression
is modified by RNAi in the during muscle fiber formation [11]. To
determine if akirin interacts genetically in vivo with twist,w e
examined the patterning of the somatic body wall musculature in
embryos that are heterozygous for both twist and akirin. While
twi
1/+ embryos [39], akirin
2/+ and akirin
3/+ embryos have a wild-
type somatic muscle pattern (data not shown), stage 16 embryos
that are heterozygous for both twist and akirin
2 and akirin
3 (twi
1/+;
akirin
2/+, and twi
1/+; akirin
3/+) show a general disruption of the
muscle pattern, with missing and misattached muscles (twi
I1/+;
akirin
2/+ : 21.6% of 60 embryos examined and twi
1/+; akirin
3/+:
18.5% of 105 embryos examined, Figure 2A).
Additionally, in vitro-translated Akirin was successfully pulled
down using a GST-Twist fusion protein indicating a physical
interaction between Akirin and Twist (Figure 2B). Taken together,
these data confirmed our initial results of the yeast double
interaction screen and demonstrated both a physical and
functional interaction between Akirin and Twist.
Dmef2 enhancer activity is reduced in akirin mutant
embryos
Akirin was initially identified in our screen as a Twist interacting
protein in the context of the Dmef2 enhancer. In addition, the
Figure 1. Akirin mutants display a range of muscle phenotypes. Lateral views of stage 16 wild-type (ii, wt) and akirin mutant (iii, iv, v)
embryos stained with anti-tropomyosin antibodies demonstrate the types of muscle phenotypes observed. All allelic combinations are listed as
maternal/paternal contribution. In all figures, anterior is to left and dorsal is up, scale bar=25 mm. Lateral transverse (LT) muscles are used to illustrate
the following predominant muscle defects observed in akirin mutants (red arrows): (iii) missing muscles, (iv) improperly attached muscles, and (v)
duplicated muscles. Schematic of wild-type muscle pattern is shown in (i). Penetrance of each defect is given in Table 1.
doi:10.1371/journal.pgen.1002547.g001
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embryos with modified Dmef2 or twist expression [7,11,40–42].
These data suggested that Akirin and Twist interact to positively
regulate transcription from Dmef2. To test this in vivo, we analyzed
akirin mutant embryos that carry a lacZ transgene regulated by the
same Dmef2 muscle enhancer [33] used in our initial double
interaction screen. This particular enhancer requires Twist activity
for early Dmef2 expression during somatic myogenesis. Regulation
of Dmef2 by Twist is critical for the subsequent establishment of the
somatic musculature [8,33,40,41,43–48]. Whole-mount antibody
staining for b-galactosidase (b-gal) indicated that akirin mutants
have reduced expression of b-gal compared to wild-type embryos
with the same transgene at the same developmental stage
(Figure 3A, 3B). Densitometric analysis of Western blotting
supported the observation that total b-gal levels were changed in
akirin mutant extracts relative to wild-type embryo extracts (Figure
S5). To confirm that endogenous Dmef2 expression levels were
affected, we performed RT-qPCR analysis on total mRNA
prepared from wild-type and akirin
2 mutant embryos at the same
developmental age (4–6 h AEL). Accordingly, we observed a 2.75-
fold reduction in Dmef2 transcripts in akirin
2 mutant embryos
compared to wild-type embryos at this time (Figure 3C).
For comparison, we examined a second Twist target gene, even-
skipped. No reduction in protein levels of Even-skipped (Eve) or
levels of expression from eveMHE-lacZ reporter constructs were
observed in akirin mutant embryos at the same stage (Figure 3B
and Figure S5). These data indicated that Twist and Akirin
interact to positively regulate expression of the Dmef2 reporter.
These data also suggested that not all Twist target genes and/or
their associated enhancer elements require Akirin activity for their
proper expression.
Akirin protein is detected at actively transcribed gene
loci
In addition to our observed relationship with Twist, Akirin has
been linked to other transcriptional regulators in various insect
and mouse contexts [29,30,49]. However, in each of these
contexts, the mechanism by which Akirin promotes gene
expression remained unclear. Because Akirin does not have a
consensus DNA-binding domain or predicted catalytic activity, we
hypothesized that Akirin regulates gene expression through its
interactions with transcriptional regulators and would therefore
localize to regions of active transcription. We analyzed the
distribution of Akirin on polytene chromosomes and found Akirin
localization throughout the genome including puffed regions of
polytene chromosomes (Figure 4A, 4B), which indicate active
transcription [50]. For further confirmation, co-immunostaining
for Akirin and Serine 10-phosophorylated histone H3, a histone
Table 1. Penetrance of muscle phenotypes in akirin mutant embryos.
Genotype Embryos examined Penetrance
a Missing muscles
b Attachment defects
b Duplicated muscles
b
akirin
2 114 46.5% 67.9% 83.0% 18.9%
akirin
2/akirin
3 52 67.0% 71.4% 68.5% 25.7%
akirin
3/akirin
5 38 44.7% 35.0% 35.0% 6.0%
wild-type 85 2.3% 1.1% 1.1% 0.0%
aPenetrance indicates percentage of mutant embryos that have a defect in n$2 hemisegments.
bPrevalence of missing, attachment, and duplication defects are given as percentage of observed defect in mutant embryos.
doi:10.1371/journal.pgen.1002547.t001
Figure 2. Akirin interacts both genetically and physically with Twist. (A) Lateral views of stage 16 wild-type (wt) and embryos heterozygous
for both twist and akirin (twi
1/+; akirin
2/+ and twi
1/+; akirin
3/+) stained with tropomyosin antibodies to visualize body wall muscles. Double
heterozygous embryos have defects in muscle patterning (indicated by red arrows), suggesting a genetic interaction between akirin and twist. Scale
bar=50 mm. (B) GST pull-down experiments indicate that GST-Twist interacts physically with in vitro expressed Akirin protein. GST-Twist pull-down of
in vitro translated Daughterless provided as positive control for pull-down. Loading of GST-fusion proteins, as verified by Coomassie staining is
provided. Note that (B) is a composite figure; lanes were omitted from the same gel for sake of clarity and direct comparison.
doi:10.1371/journal.pgen.1002547.g002
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polytene chromosomes, was performed [51–53]. Akirin partially
colocalized with Ser10-phosphohistone H3 staining (43.8%
colocalization, see Figure 4C, 4E and Figure S6A). To strengthen
these results, we performed additional co-immunostaining for
Akirin and Ser7-phosophorylated RNA polymerase II [54], which
also showed partial colocalization between these two stains
(55.4%, see Figure 4D, 4F and Figure S6B). These data confirmed
Figure 3. Dmef2 enhancer activity is reduced in akirin mutants. Confocal micrographs of two hemisegments of transgenic late stage 11 wild-
type (A) and akirin
2 homozygous embryos (B) containing the Dmef2-lacZ reporter construct [33] showing immunoreactivity to b-galactosidase (red)
and Even-skipped (Eve, green). Dmef2-lacZ reporter expression was reduced in akirin
2 mutants compared to wild-type embryos. Images of wild-type
and akirin
2 embryos were acquired with identical exposure settings (see Materials and Methods). (C) RT-PCR of Dmef2 mRNA isolated from 4–6 hour-
old wild-type and akirin
2 mutant embryos demonstrates that Dmef2 expression is reduced in akirin
2 mutants. Bar in (A) and (B)=20 mm.
doi:10.1371/journal.pgen.1002547.g003
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PLoS Genetics | www.plosgenetics.org 5 March 2012 | Volume 8 | Issue 3 | e1002547Figure 4. Akirin protein is broadly distributed throughout the genome. (A,B) Polytene chromosomes were prepared from wild-type larvae,
immunostained with antibody against Akirin and counterstained with DAPI to visualize DNA. Akirin is distributed at many sites throughout the
genome and found at both puffed (arrows in (B)) and non-puffed (* in (B)) regions. (C,D) Detail of wild-type polytene chromosomes immunostained
with antibodies against Akirin (green) and (C) Ser10-phosphorylated histone H3 (red) or (D) Ser7-phosphorylated RNA Polymerase II (red) indicate that
Akirin is found at some but not all regions of active transcription in polytene chromosomes. See Figure S6 for whole-genome squashes. Split
presentation provided to compare banding pattern. White arrows indicate colocalization, white arrowheads indicated Akirin-only bands, black
arrowheads indicate Akirin-negative bands. (E,F) Quantification of colocalization between Akirin and (C) Ser10-phosphorylated histone H3 and (D)
Ser7-phosphorylated RNA Polymerase II. (G) Twist and Akirin colocalize at Twist targets in polytene chromosomes. Chromosome squashes were
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throughout the genome. In addition, because Twist is not
expressed in wandering third instar salivary glands ([55] and data
not shown), these data suggested that Akirin interacts with other
transcriptional regulators for its function in this tissue. However,
when we ectopically expressed Twist in the salivary glands using
Sgs3-GAL4 [56], we found that Twist and Akirin partially
colocalize on polytene chromosomes (54% colocalization,
Figure 4G). Furthermore, under these conditions both Twist and
Akirin colocalized at the Dmef2 locus (Figure 4G), and Dmef2,
which is not normally expressed in salivary glands, is now
expressed (Figure S7). We note that Akirin is not localized to the
Dmef2 locus when Twist is not present (Figure 4H). Together, these
data supported our earlier results indicating that Akirin acts with
Twist to promote the expression of a Twist-regulated target.
Finally, the colocalization of Akirin with regions of active gene
expression in a tissue that does not normally contain Twist
confirmed that Akirin functions as a general regulator of gene
expression.
Akirin colocalizes with components of the Brahma
chromatin remodeling complex
One mechanism whereby Akirin might function as a general
cofactor for gene expression would be through interactions with
chromatin remodeling complexes. A Drosophila whole-genome
yeast 2-hybrid experiment [57] suggested that Akirin interacts with
BAP60, a core subunit of the Drosophila SWI/SNF class Brahma
(BRM) chromatin remodeling complex [58]. Immunostaining of
polytene chromosomes with antibodies against the Brahma
(Figure 5A) and Snr1 (Figure 5B) core subunits revealed that
Akirin colocalized with BRM (67% and 59.1% colocalization
respectively, Figure 5D and Figures S8, S9). Akirin also colocalized
with Osa (65.3% colocalization), a subunit exclusive to the BAP
complex (Figure 5C, 5D and Figure S9). These data therefore
suggested that Akirin associates with BRM complex components
but is not a core BRM complex subunit.
Akirin interacts with BRM complex subunits during
embryonic myogenesis
Given the observed colocalization between Akirin and the
Brahma, Snr1 and Osa BAP subunits on polytene chromosomes,
we hypothesized that there is a functional association of these
proteins during embryonic development. To test this, the
patterning of the somatic muscles in stage 16 embryos that are
double heterozygotes for both akirin and brahma was examined
(Figure 6B). Both brm
I21/+ and akirin
2/+ (single heterozygous)
embryos have a normal somatic muscle pattern (Figure S10), but
the brm
I21/+,akirin
2/+ double heterozygous embryos (35%, n=55)
displayed disruptions in the somatic muscles, with both missing
and improperly attached muscles (Figure 6B, Table 2). We further
analyzed embryos that are double heterozygotes of both akirin and
other BRM complex core subunits (Figure 6, Table 2). Although
heterozygous embryos for other BRM complex subunits do not
show a somatic muscle phenotype (Figure S10), muscle phenotypes
were observed in akirin
2/+,moira
1/+ (40%, n=48, Figure 6C),
akirin
2/+,Snr1
01319/+ (45%, n=52, Figure 6D), and Bap60
1/
+;akirin
3/+ embryos (40%, n=55, Figure 6E). Additionally,
akirin
2/+,bap180
D86/+ (38%, n=45, Figure 6F) and akirin
2/
+,osa
2/+ (42%, n=52, Figure 6G) embryos also had disrupted
muscle patterning. To ensure that these defects were specific for
subunits of the BRM complex and not due to a general interaction
between akirin and other chromatin factors, double heterozygous
combinations of akirin with alleles of Polycomb, Nurf-38, Iswi, and
Su(var)3-9 were tested. Each of these allelic combinations showed
muscle patterning defects in fewer than 5% of embryos. These
results confirmed a functional interaction during muscle develop-
ment between Akirin and core BRM subunits, as well as PBAP
and BAP-specific subunits. Based on our data thus far, we
hypothesized that Akirin mediates Twist-BRM interactions on a
subset of Twist target genes. To begin to test this, we examined
whether whether twi and brm genetically interact. We find that the
somatic muscle pattern is disrupted in twi
I1/+; brm
I21/+ double
heterozygous embryos (23%, n=51, Figure 6H), supporting a
functional interaction between twist and brahma.
To determine whether the Akirin protein associates with the
BRM complex in vivo, we attempted co-immunoprecipitation
experiments from embryonic lysates using tagged Akirin. While we
did observe weak physical interaction between tagged Akirin and
the Brahma core subunit (data not shown), these appear to be
highly transient and not robust. As we had identified a functional
interaction between twist and brahma (Figure 6H), we examined
whether Brahma and Twist physically interact. Antibodies against
Brahma successfully co-immunoprecipitated Twist from whole
embryonic extracts (Figure S11). Together these data suggest that
Twist and Akirin both interact functionally with the BRM
complex during myogenesis.
Twist, Akirin, and a core BRM complex subunit are
localized to Twist-dependent enhancers in vivo
To further support our interaction data, we next tested whether
Twist, Akirin, and the BRM complex were localized to Twist-
regulated enhancer elements in embryos when the muscle pattern
is being established. Using chromatin immunoprecipitation and
quantitative PCR, we examined the occupancy of the Dmef2
enhancer and the eve MHE element by Twist and Akirin (Figure 7).
Both of these enhancer regions contain E-box elements that are
bound by and regulated by Twist during development
[8,33,46,59]. In agreement with previously published data [8],
antibodies against Twist and Akirin both successfully immuno-
precipitated the Dmef2 enhancer in extracts prepared from 2–4
and 4–6 hour-old embryos (Figure 7A, 7B). These data suggested
that Akirin localizes to the Dmef2 enhancer element with Twist
during these time periods. However, while Twist occupancy at the
eve MHE was detected as previously reported [8], Akirin protein
was not significantly enriched at the eve MHE region in 2–4, 4–6,
and 6–10 hour embryo extracts compared to preimmune antisera
controls. We concurrently examined occupancy of these elements
by Twist and Akirin in extracts prepared from akirin
2 mutant
embryos. As we would predict, Twist occupancy at both Dmef2 and
eve MHE enhancers was not significantly affected by the absence of
Akirin (Figure 7A).
We next tested the occupancy of Dmef2 and eve MHE enhancers
by a BRM subunit. We found that the BRM core subunit Moira
occupied the Dmef2 enhancer early, in extracts prepared from 2–
4 hour old embryos (Figure 7C), with a similar occupancy profile
as that observed with Twist at this time. However, the reduction in
prepared from larvae expressing Twist under the control of the Sgs3-GAL4 driver (Sgs3-GAL4.UAS-twist). Polytenes were hybridized with DNA probes
against exon 8 of Dmef2, and further immunostained with antibodies against Akirin (green) and Twist (red). Both Twist and Akirin localize to the
Dmef2 locus (arrow) when Twist is expressed in salivary glands. (H) Akirin does not localize to the Dmef2 locus in salivary glands that do not express
Twist. Scale bar in all images=5 mm.
doi:10.1371/journal.pgen.1002547.g004
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enhancer, as we observed a 64% reduction in Moira levels at this
enhancer in 2–4 hour old akirin
2 mutant extracts versus wild-type.
We further found that Moira occupied the eve MHE, albeit at
relatively low levels, at all time points examined. Further, this
occupancy was not affected by the absence of Akirin, as the levels
did not appear to change in akirin
2 mutant extracts versus wild-
type (Figure 7C). For comparison, we also examined occupancy of
Twist, Akirin and Moira at the enhancer region of the oskar gene,
which is not normally expressed in the embryo at this time [60].
We found no detectable occupancy of any of these factors at this
region at the same timepoints (see Figure S12). In summary, we
find that Twist, Akirin, and core subunits of the BRM complex all
co-occupy the Dmef2 Twist-dependent enhancer together at a
temporally critical time for establishing the muscle pattern during
embryogenesis, and the occupancy of Moira at this element is
dependent upon the presence of Akirin. In contrast, we find that
Akirin is not present at a second Twist-regulated enhancer, the eve
MHE, at the same period of embryonic development.
Discussion
The Twist transcription factor controls many key processes in
the establishment and patterning of the mesoderm, including
organogenesis of the somatic body wall musculature during
Drosophila embryonic development [6]. As Twist activity regulates
a large number of genes and processes over the course of
mesodermal development [8,9], specific Twist functions are likely
conferred through secondary and tertiary proteins that interact
with Twist [11]. In a screen for such interacting proteins, we
identified the highly conserved nuclear protein Akirin. Akirin
mutants show defects in myogenesis consistent with a role in
regulating Twist activity, in particular at the Dmef2 gene. Akirin
accomplishes this regulation through interactions with core
subunits of the Brahma chromatin remodeling complex. Finally,
we find Twist, Akirin and a BRM complex subunit all co-occupy
the Dmef2 enhancer during early embryogenesis, and this
occupancy of a core BRM subunit requires the presence of
Akirin. These data suggest that Akirin is required for optimal
expression of this Dmef2 enhancer element. By contrast, the Twist-
regulated eve MHE regulatory element does not require Akirin for
its expression. Together, these results suggest that Akirin is an
accessory protein that links Twist and the BRM chromatin
remodeling complex for activation of specific Twist-regulated
enhancers during Drosophila embryonic development. We propose
that this Akirin-mediated link between Twist and the Brahma
complex represents a novel paradigm for providing tissue and
target specificity for Twist transcription factor activity with
chromatin remodeling machinery during embryogenesis.
Akirin and Twist interact during embryonic development
Establishment of the somatic musculature during embryogenesis
requires precisely regulated Twist activity [4]. The muscle
phenotype of akirin mutants and twist and akirin double
heterozygotes indicates a functional interaction between Twist
and Akirin during myogenesis. This interaction is direct, as Akirin
and Twist physically bind. Additionally, both Twist and Akirin co-
occupy the Dmef2 enhancer during embryogenesis, and their
association is important for robust expression from the Dmef2
enhancer. Dmef2 is a critical regulator of myogenesis and is
expressed throughout this process [33,40,45,47,48]. Dmef2
coordinates multiple processes necessary for proper somatic
myogenesis and regulates, in combination with Twist, a subset of
Twist-regulated genes in a feed-forward manner [8,47]. The
Figure 5. Akirin colocalizes with subunits of the SWI/SNF-class
Brahma chromatin remodeling complex. (A–C) Detail of polytene
chromosome squashes demonstrating immunocolocalization of Akirin
with Brm complex subunits. See Figure S9 for whole genome squash
images. (A) To avoid cross-reactivity between Akirin and Brahma
primary antibodies, polytene chromosomes were prepared from larvae
expressing HA-tagged Akirin (UAS-Akirin-HA) under control of the Sgs3-
GAL4 driver, and immunostained with antibodies against HA (green)
and Brahma (red). Extensive colocalization was observed between
Akirin-HA and Brahma (white arrows). Examples of Akirin-HA immuno-
stain without Brahma colocalization (white arrowhead), and Brahma
signal without Akirin colocalization (black arrowhead) are indicated. See
Figure S8 for comparison of Akirin-HA and endogenous Akirin
immunolocalization. (B,C) wild-type polytene chromosomes were
immunostained with antibodies against Akirin (green) and Snr1 (B) or
Osa (C). Examples of Akirin signal without corresponding Snr or Osa
colocalization are indicated (white arrowhead), and Snr or Osa signal
without corresponding Akirin immunostain (black arrowhead) are
indicated. (D) Quantification of colocalization/non-overlap between
Akirin and Brm complex subunits -positive polytene bands in (A–C).
Scale bar in all images=5 mm.
doi:10.1371/journal.pgen.1002547.g005
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observe in akirin mutants are similar to the phenotypes of embryos
in which Dmef2 or twist expression levels are modified [11,40–42].
For example, missing and misattached muscles were reported in
incompletely rescued Dmef2 mutant embryos [41], while muscle
duplications have been reported as a result of RNAi-mediated
knockdown of twist [11]. Therefore, akirin mutant muscle
phenotypes likely reflect a perturbation in Twist activity, resulting
in an early alteration in Dmef2 expression levels during
embryogenesis. There are other elements in the Dmef2 enhancer
that are bound and controlled by transcription factors such as
Pannier, Medea and Tinman, that regulate Dmef2 expression
during embryogenesis [8,33,46,59]. It is unknown whether Akirin
interacts with these factors at other Dmef2 control elements for
their optimal expression or whether interaction with just one factor
is sufficient. These questions are subjects for further study.
Whole genome ChIP-on-chip experiments have identified
almost 500 cis-regulatory elements that are bound by Twist
during mesodermal development [8]. Further, Twist co-regulates
a number of targets together with Dorsal, Dmef2 and Tinman in
a feed-forward manner. Interestingly, our data would argue that
Twist does not require Akirin for optimal expression of all Twist-
dependent enhancers. First, our analysis of polytene chromo-
somes indicates that Akirin colocalizes with Twist at only 54% of
Twist binding sites. Second, our chromatin immunoprecipitation
experiments indicate that Akirin is enriched at the Dmef2
enhancer during the first 10 hours of embryonic development,
but not at the even-skipped MHE enhancer at the same time.
Accordingly, we did not observe a noticeable decrease in Eve
expression, a reduction in Eve-positive clusters, or defects in
patterning of the DA1 muscle in akirin mutants (Figure 3, Figure
S3, and data not shown). What could explain the different
requirements for Akirin for optimal expression of Dmef2 versus
eve? On one level, there are inherent differences in the
complexities of these enhancers: While both the eve MHE and
Dmef2 enhancers contain E-boxes bound and regulated by Twist,
Figure 6. Akirin interacts genetically and physically with BAP and PBAP subunits during embryonic myogenesis. (A–G) Lateral views
of stage 16 Wild-type (wt) and embryos heterozygous for both akirin and indicated subunits of BAP and PBAP complexes. All embryos stained to
reveal somatic musculature with tropomyosin antibodies. Thin red boxes in whole embryo photos indicate region shown in higher magnification for
each embryo. Double heterozygous embryos have defects in general muscle pattering, suggesting a genetic interaction between akirin and
components of the BRM chromatin remodeling complex (See Table 2 for quantification of defects). (H) Lateral view of stage 16 embryo heterozygous
for both twist and brahma. Muscle patterning defects observed in these embryos suggest a genetic interaction between twist and brahma (A,C). Scale
bar in panels A–H=50 mm.
doi:10.1371/journal.pgen.1002547.g006
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bound by a large array of factors from the Wingless,
Decapentaplegic, and RTK-Ras-MAPK pathways [59]. This
greater complexity of regulation may obviate the need for Akirin
to achieve optimal expression. On another level, the difference in
Akirin regulation of these enhancers could be reflected in the
local chromatin environment of these enhancers, and whether the
individual enhancer needs to be remodeled by SWI/SNF activity
for optimal expression. Analysis of deposited Modencode data
[61] suggests that the histone modification profile of the eve MHE
remains largely static during the same temporal window as our
chromatin immunoprecipitation experiment, while the environ-
ment surrounding the Dmef2 enhancer element changes during
this same time (data not shown). Further studies are required to
identify the basis of this different requirement for Akirin at these
Twist targets. Our polytene analysis indicates that a large number
(.200) of Akirin-positive bands colocalize with Twist in the
genome (Figure 4). Identifying the complete list of Twist target
genes that require Akirin will likely yield further clues as to the
regulatory logic of Akirin together with chromatin remodeling
during Twist target expression.
Akirin interactions with transcription factors other than
Twist
Our data establishes Akirin as a Twist-interacting protein that
promotes expression from a Twist-regulated enhancer; however,
the results presented in this study also indicate that Akirin does not
act solely with Twist.Analysis of salivary gland polytene chromo-
somes demonstrated that Akirin is associated with numerous
actively transcribed gene loci. Twist is not normally expressed in
salivary glands, therefore this result suggests that Akirin has roles
in activation of non-Twist regulated genes. Moreover, the
widespread expression of Akirin throughout the entire embryo
suggests that specificity of Akirin function is determined not by
restriction of Akirin expression, but rather by the associated
transcription factor. Indeed, potential interactions between Akirin
and other transcription factors have been described: Akirin
misexpression enhances phenotypes resulting from mutations in
the GATA-2 homologue pannier [62]. Additionally, whole genome
yeast 2-hybrid analysis [57] suggests an interaction between Akirin
and Charlatan, a zinc-finger transcription factor involved in
development of the peripheral nervous system [63]. Finally, recent
work has identified Akirin as a promyogenic factor and target for
Myostatin regulation [30], as well as NF-kB target gene expression
in the Drosophila innate immunity pathway [29]. Taken together,
these interactions with transcription factors other than Twist, and
roles in non-Twist-dependent pathways further support our model
whereby Akirin functions as a general transcription cofactor. We
propose that the regulatory mechanism involving Akirin and the
Brahma chromatin remodeling complex at specific enhancers is
applicable to these transcriptional regulators in these other
contexts. Further experimentation is required to validate this
model.
Akirin is likely a novel accessory of the Brahma chromatin
remodeling complex
Our studies identify Akirin as a nuclear factor that genetically
interacts with the BRM complex and is required for optimal
expression of the Twist-dependent Dmef2 enhancer. This
association between Akirin and BRM complexes is likely the
mechanism whereby Akirin is linked to gene activation. The
Brahma complex (BRM) promotes gene activation by remodeling
the local chromatin environment allowing components of the
general transcription machinery greater accessibility to the DNA
[15]. BRM complexes are tightly associated with regions of
transcriptionally active chromatin, and are associated with both
promoter paused (initiating) and actively elongating RNA
Polymerase II complexes throughout the Drosophila genome
[23]. Although a strong physical association of BRM complexes
with RNA Polymerase II has not been confirmed, loss of BRM
function leads to a severe impairment in transcription by RNA
polymerase II [23]. Based on our genetic and ChIP data, we
conclude from our results that Akirin is not a core BRM subunit,
but is rather an accessory protein that is capable of interacting
with BRM complexes. We base this conclusion on the
observation that the distribution of Akirin and BRM subunits
on polytene chromosomes do not completely overlap, and
because numerous biochemical analyses of BRM complex
composition to date have failed to identify Akirin as a BRM
subunit [24,64]. Further, we did not observe a specific interaction
of akirin with either BAP or PBAP complex-specific subunits
during myogenesis (Figure 6). In Drosophila, both BAP and PBAP
complexes have both been linked to gene activation and
repression, are present in the same cells, and perform unique,
yet cooperative, functions during development [15,16,19,24–28].
Indeed, while we were able to observe weak physical interactions
between Akirin and the Brahma core subunit in vivo (data not
shown), these interactions were not overly robust. Moreover, it is
unknown if Akirin needs to be post-translationally modified or to
further associate with other factors to mediate a physical
interaction with the Brahma subunit. Further, while we tested
interactions with the core Brahma subunit, it remains to be
determined whether Akirin may be interacting instead with other
core BRM subunits. Nevertheless, our data strongly suggests a
likely association as an accessory of the BRM complex. As an
accessory protein, Akirin would likely confer tissue, target, and
even temporal specificity on BRM complex activity by connecting
BRM complexes with a particular transcription factor for
promotion of gene expression (see below).
Interactions among Akirin, BRM complexes, and Twist
Our data suggest that Twist target genes have different
requirements for the presence of chromatin remodeling factors
during gene activation and imply that the chromatin environments
at these genes are varied. This also would suggest that the local
Table 2. Genetic interactions between akirin and BRM
complex subunit genes.
Genotype Embryos examined % disrupted muscles
a,b
twi
1/+; akirin
2/+ 60 21.6%
twi
1/+; akirin
3/+ 105 18.1%
akirin
2/+,brm
I21/+ 55 35%
akirin
2/+,moira
1/+ 48 40%
akirin
2/+,Snr1
01319/+ 52 45%
Bap60
1/+; akirin
3/+ 109 20.2%
akirin
2/+,osa
308/+ 52 42%
akirin
2,bap180
D86 45 38%
twi
1/+;b r m
I21/+ 51 23%
aPercentage of all stage 16 embryos examined that have missing, misattached,
or duplicated muscles in 2 or more hemisegments.
bCrosses of akirin mutants with control balancer stocks (n.50) showed similar
defects in .5% of stage 16 embryos examined.
doi:10.1371/journal.pgen.1002547.t002
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developmental time. Further experiments will be required to
validate this hypothesis. As an accessory protein, Akirin optimizes
Twist transcription factor activity outputs. Akirin likely accom-
plishes this optimization by facilitating an interaction between
Twist and BRM complexes and as such, we would predict, change
the local chromatin environment to one more favorable for
transcription. The exact nature of the interface between bHLH
transcription factors such as Twist and chromatin remodeling
complexes such as BRM has not been previously determined. Our
data would suggest that Akirin would be a suitable candidate for
mediating this relationship between Twist and chromatin
remodeling complexes. Mammalian SWI/SNF complexes are
positively associated with bHLH transcription factor activity;
however, the precise role of their remodeling activity during
expression of bHLH target genes remains unclear [65]. Whether a
similar linkage via Akirin is at play with mammalian Twist during
development or in a cancer context remains to be tested.
Nevertheless, in keeping with our proposed model of Akirin
function, our data suggest a relationship between Twist and BRM
during development: twi
I1/+;brm
2/+ double heterozygous embryos
show muscle patterning defects similar to twi
1/+;akirin
2/+ double
heterozygotes (Figure 6). Also, forced expression of Twist in
salivary glands and subsequent analysis of colocalization on
polytene chromosomes indicated that Twist and Brahma coloca-
lized 58% of the time (Figure S11), a frequency similar to that
observed between Twist and Akirin (54%, Figure 4 and data not
shown).
Our finding that early (i.e., 2–4 hours) occupancy of the Moira
core subunit at the Dmef2 enhancer was decreased in akirin mutants
would suggest that Akirin contributes to BRM complex localiza-
tion. However, our co-immunoprecipitation experiments (data not
shown) would suggest that any physical interaction between these
two proteins would be either highly transient, or exquisitely
sensitive to the presence of interfering factors such as protein tags.
Therefore, the mechanism by which Akirin would increase Moira
occupancy remains unclear. The result of such a recruitment or
stabilization of BRM complexes by Akirin at Twist-target loci,
would presumably result in remodeling of the local environment
by BRM for optimal gene expression. Further experiments, aimed
at understanding the nature of the Akirin/BRM complex
association are currently underway. Together, this association
between Twist, Akirin and the BRM complex would provide a
novel mechanism linking chromatin remodeling factors to
spatiotemporal-specific gene activation by the Twist transcription
factor. Our work provides another venue to investigate how
changes in the chromatin environment at specific targets leads to
optimal gene expression and how these local changes impact the
development of specific tissues.
Figure 7. Akirin and the BRM complex co-occupy the Dmef2
enhancer during embryogenesis. Chromatin immunoprecipitations
were performed on extracts prepared from 2–4, 4–6, and 6–10 hour-old
yw (Blue bars) and akirin
2 mutant (Red bars) embryos using anti-Twist
(A), anti-Akirin (B), and anti-Moira (C) antibodies. The presence of the
Dmef2 enhancer or even-skipped MHE enhancer (eve MHE) was assayed
in precipitated DNA samples using quantitative PCR. Values for
preimmune (stippled bars) and immunoprecipated samples (solid color
bars) are presented as percent of total input fraction. Akirin and the
core BRM subunit Moira both co-occupy the Dmef2 enhancer with Twist
in 2–4 and 4–6 hour-old embryos. The occupancy of Moira at this
enhancer appears to be Akirin-dependent, as Moira occupancy
decreases by approximately 64% in akirin mutant extracts. (A–C) While
Twist and Moira occupy the eve MHE enhancer, Akirin is not enriched at
this region in wild-type or mutant extracts, and the absence of Akirin
does not affect the occupancies of either Twist or Moira.
doi:10.1371/journal.pgen.1002547.g007
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Drosophila genetics
Flies were reared using standard conditions. Three different
alleles of akirin were used: akirin
KG01343 (referred to in this work as
akirin
2), akirin
EY08097 (akirin
1) and akirin
EP(3)0906 (akirin
3). akirin
1 and
akirin
2 are viable P-element insertions into the first intron of akirin,
while the homozygous lethal akirin
3 allele is an insertion into the
first exon (Figure 1A). We further generated two additional
homozygous lethal akirin alleles by excision of the akirin
1 (EY08097)
P-element (akirin
4 and akirin
5). Mobilization of the EY08097 P-
element resulted in the isolation of two different mutations: akirin
5,
which is an insertion of approximately 1 kb of DNA into the
second akirin exon due to incomplete P-element excision, and
akirin
4, which is a deletion of 6 kb containing the first exon and
intron of akirin, as well as a portion of the upstream SH3b open
reading frame. The akirin
EP(3)0906 mutant chromosome possessed a
second unidentified lethal mutation in addition to the EP(3)0906
insertion. This second lethal mutation was removed by recombi-
nation with a rucuca-marked chromosome [66] to produce the
akirin
3 line used in this study. akirin
3, akirin
4, and akirin
5
homozygous mutant embryos die shortly after stage 16 and do
not hatch into larvae (data not shown). For analysis, akirin
3, akirin
4,
and akirin
5 were balanced over TM3, Dfd-lacZ or TTG [67]. For
genetic interactions, the following alleles were used: moira
1,
Snr1
01319, brm
2 and brm
I21 (Bloomington stock collection). osa
308
and bap180
D86 (a gift of J. Treisman), Bap60
1 (a gift of G. Mardon),
nurf
38, Iswi
1, and Su(var)3-9
1 (a gift of V. Corces), and twi
1 [39].
Dmef2-lacZ [33] and eveMHE-lacZ (a gift of A. Michelson) were
used for expression studies. GAL4 expression lines [68] used were
twi-GAL4;Dmef2-GAL4 [69] and Sgs3-GAL4 [56]. OreR and yw flies
were used as wild-type stocks where indicated. Germline clones
[37] were generated by heat shock of hs-FLP; ovoD
1,FRT2A/
akirin
3,FRT2A larvae. Germline clone females were then mated to
akirin
3/TM3,Dfd-lacZ at 20–22uC to create akirin
3 maternal/
zygotic embryos.
Production of UAS-HA–tagged Akirin flies
The HA-tag was fused in-frame at the Akirin C-terminus using
PCR techniques (Table 3). PCR products were cloned into pUASt
and injected into yw embryos as described [4]. Multiple
independent transformant lines were generated and evaluated
for Akirin-HA expression.
Double-interaction screen
Briefly, we adapted the method described by L. Pick and
colleagues [31]. Enhancers tested were the 175-bp upstream
enhancer of Dmef2 [33] and the 375-bp enhancer contained in the
first intron of the tinman gene [34] cloned upstream of a HIS3
reporter. Reporter strains were created using these constructs.
Screening for Twist-interacting proteins was performed by
introducing a cDNA library prepared from 0–6 hour Drosophila
embryos fused to the GAL4 activation domain [31]. Akirin was
identified as a cDNA that expressed the HIS3 reporter in a Twist-
dependent manner at both Dmef2 and tinman enhancers [32].
Immunohistochemistry and production of Akirin
antibody
Antibodies and dilutions used: anti-tropomyosin (1:1000,
Abcam), anti-myosin monoclonal antibody (1:500, a gift of S.
Abmayr), anti-Twist (1:100, a gift of M.Levine) anti-Osa (1:50,
DSHB), anti-Brm (1:50, gift of C.P. Verrijzer), anti-HA 3F10
(1:25, Roche), anti-Dmef2 (1:1000, a gift of B. Patterson), anti-
Snr1 (1:100, gift of A. Dingwall), anti-Eve (1:3000, a gift of M.
Frasch), anti-phosphohistone H3 (mouse monoclonal, 1:100,
Millipore), anti-Serine-7-phosphorylated RNA polymerase II
(1:100, Millipore) and anti-b-galactosidase (1:1000, Abcam).
Whole-mount embryo immunohistochemistry was performed as
described [70]. Comparison of b-galactosidase expression levels in
wild-type and akirin mutant embryos was performed as per [11].
For production of polyclonal Akirin antibody, the peptide
sequence of CESMIKERENQLR corresponding to residues
151–163 in full-length Drosophila Akirin was synthesized and
Table 3. Primers used in this study.
Sequence Purpose
59-CGCCTCGAGGCTTAGCCAGCGTAGTCTGGGACGTCGTATGGGTACGACAGGTAGCTAGGCGCTGC- 39 Upstream primer for HA-tagging of Akirin
59-CTCCCCCGTCTCCATAAAGGTC-39 Upstream primer- production of Dmef2 ISH probe
59-GTTGCTACTGGTGCTGCTGCTG-39 Downstream primer- production of Dmef2 ISH probe
59-AACTGCCAAGCGTGTGCCGTGT-39 qPCR detection of Dmef2 transcript- upstream primer
59-CAAGGCCAAAGGGGCAGCACCA-3 qPCR detection of Dmef2 transcript- downstream primer
59-CTTCTTCAGCGACACCCATT-39 qPCR detection of GAPDH transcript- upstream primer
59-ACCGAACTCGTTGTCGTACC-39 qPCR detection of GAPDH transcript- downstream primer
59-CCGATGCTGCTGCTGCTGCTACT-39 Forward qPCR primer used in ChIP of Dmef2 enhancer (-2344)
59-GACCATGTACCCCGATGCTGTGC-39 Reverse qPCR primer used in ChIP of Dmef2 enhancer (-2257)
59- CTCCCCCGTCTCCATAAAGGTC-39 Forward qPCR primer used in ChIP of Dmef2 ORF (+11007)
59- GTTGCTACTGGTGCTGCTGCTG-39 Reverse qPCR primer used in ChIP of Dmef2 ORF (+10782)
59- GGAAATCGTCTTGGGATGCGAGTGGT-39 Forward qPCR primer used in ChIP of eve MHE region (+6171)
59- AGCTGCAGATCCGGACTCGCAATAG-39 Reverse qPCR primer used in eve MHE region (+6334)
59- CTGGGTCGCTTGGAGAAGGAGTT-39 Forward qPCR primer used in ChIP of eve ORF (+490)
59- CGATCCTCTGACGCTTGTCCTTC-39 Reverse qPCR primer used in eve ORF (+616)
59-TGCGAATGGTCTTCATGGAA-39 Forward qPCR primer used in ChIP of oskar enhancer (+8117)
59-CACCGTCAAGCAGCGTGTAC-39 Reverse qPCR primer used in ChIP of oskar enhancer (+8182)
doi:10.1371/journal.pgen.1002547.t003
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immunoreactivity using pre-immune serum as a negative control
(See Figure S2).
Microscopy
Bright field and immunofluorescent images were obtained using
a Zeiss Axiophot microscope. Images were processed using Adobe
Photoshop. Confocal images were acquired using either a Zeiss
LSM 510 confocal scanning system mounted on an Axiovert
100 M microscope equipped with a 6361.2 NA C-Apochromat
water objective, or a Leica SP5 confocal microscope equipped
with a 6361.4 NA HCX PL Apochromat oil objective. Pinholes
were set to capture optical slices of 1.0 mm. All images were
processed using Adobe Photoshop. Maximum intensity projections
of confocal Z-stacks were rendered using Volocity Visualization
(Improvision).
GST-pulldown assays
Twist was cloned into pGEX-2T in frame and fusion protein
expressed via IPTG induction. Glutathione Sepharose 4B beads
(Amersham Pharmacia Biotech) bound with GST or GST-Twist
were suspended in ZTx buffer (25 mM HEPES, pH=7.5,
12.5 mM MgCl2, 20% glycerol, 0.1% Triton-X 100, 150 mM
KCl)+0.25 mg/ml BSA and 1 mM DTT and incubated for
10 mins with rotation.
35S-Methionine-labeled Akirin and Daugh-
terless proteins were produced in vitro using the TnT coupled
reticulocyte lysate system (Promega). Beads and translated proteins
were then incubated at room temperature with rotation for
1 hour. Beads were spun and washed in NETTx buffer (20 mM
Tris, 100 mM NaCl, 1 mM EDTA and 0.25% Triton-X 100).
Proteins were eluted from beads by boiling in Laemmli sample
buffer and resolved by SDS-PAGE. Gels were fixed in 50%
Methanol, 10% Acetic Acid, incubated in Amplify solution
(Amersham Pharmacia Biotech), and dried for autoradiography.
Western blotting
Whole-embryo extracts were prepared and resolved by SDS-
PAGE as described [71]. Western detection was performed as
described [72]. Antibodies and dilutions used: anti-Dmef2 (rabbit,
1:1000) (a gift of B. Patterson), anti-alpha-tubulin (mouse, 1:5000)
(Sigma), anti-Brahma (1:1000) (a gift of C.P.Verrijzer), anti-b-
galactosidase (mouse, 1:1000) (Promega).
Densitometry
Autoradiographs were scanned using a BioRad GS-800
Calibrated Densitometer to determine optical density of each
band, which was then divided by the area examined. For analysis
of b-galactosidase levels (see Figure S5), this value was normalized
to similar results obtained from anti-a-tubulin loading controls.
For analysis of co-immunoprecipitations (see Figure 6), this value
was reported as a percentage of the input sample analyzed. For
each condition, background (chosen from blank region of the film
piece, with no sample present) was subtracted from all analyzed
regions prior to analysis.
Polytene chromosome immunohistochemistry, in situ
hybridization, and immunocolocalization analysis
Polytene squash preparations and immunostaining was per-
formed as described [52]. For colocalization analysis, separate
channel information was compared for signal bands in polytene
squashes. Contrast settings were set to maximum for each channel,
eliminating .80% of the background signal. A band was scored as
‘‘colocalized’’ when it appeared in both channels. Bands that
appeared solely in either signal channel were scored accordingly.
A minimum of 150 bands were counted from at least three
different squash preparations. Data was plotted in percentage bar
graphs using Microsoft Excel.
In situ probes were generated using the Roche DIG-labeled
PCR kit, using oligonucleotides to amplify exon 8 of the Dmef2
open reading frame (Table 3). In situ probe purification and
hybridization was performed as described [73]. Following
hybridization, slides were washed in increasing stringency SSC
solutions, and then incubated in polytene buffer. Antibody staining
was carried out as described above, using 1:100 rhodamine-
conjugated anti-DIG antibodies (Roche) to detect DIG-labeled
probes.
Production of cDNA and quantitative PCR
wild-type (yw) and akirin
2 embryos were collected on 10 cm
apple juice agar plates and allowed to grow to 4–6 hours of age
after egg laying. Embryos were dechorionated in bleach and
homogenized in RNA TriReagent (Sigma). Total mRNA was
prepared according to manufacturer’s instructions, and resus-
pended in RNAse-free water. Following purification, total mRNA
was treated with DNAseI to degrade genomic DNA, and re-
purified using phenol:chloroform. 1 microgram of total mRNA
was used to prepare first-strand cDNA using the RevertAid First
Strand Synthesis Kit (Fermentas). First-strand product was diluted
to produce a working concentration of 10 ng/mL. For quantitative
PCR, first-strand cDNA product was diluted 1:2 with Lightcycler
480 SYBR green master mix (Roche). qPCR was conducted using
a Lightcycler 480 qPCR machine (Table 3). qPCR results were
analyzed and relative ratios of Dmef2 transcripts (normalized to
GAPDH levels) in yw and akirin
2 mutants were determined using
described methods [74].
Co-immunoprecipitations
Total nondenatured extracts were prepared from yw embryos
collected on apple juice plates. To prepare total nondenatured
extracts, embryos were dechorinated in 50% bleach, rinsed in
distilled water, and immediately homogenized in one mL of
extraction buffer (50 mM HEPES, pH 7.6, 385 mM NaCL, 0.1%
Tween-20, 0.1 mM EGTA, 1.1 mM MgCl2 and 100 mg/mL
PMSF, and 1 mg/mL each of Aprotinin, leupeptin, and pepstatin
A), using a 1 mL Dounce homogenizer. Extracts were spun at
15,000 g at 4uC to pellet debris. Supernatants were removed and
following the addition of glycerol to 10%, extracts were snap-
frozen in liquid nitrogen before storing at 280uC for later use. For
immunoprecipitations, extracts were thawed and quantitated using
the BCA assay method (Pierce). Extracts were diluted in IP buffer
(10 mM HEPES pH 8, 100 mM NaCl, 10% glycerol, 0.05%
Tween-20, 100 mg/mL PMSF, and 1 mg/mL each of Aprotinin,
leupeptin, and pepstatin A) to produce a final concentration of
3 mg/mL of total protein. Extracts were incubated with 10 mLo f
anti-Brahma antibody (a gift of P. Verrijzer) for 1 hour at 4uC.
Immunocomplexes were pulled-down using 20 mL of a 50%
protein A-agarose slurry. Beads were washed four times at 4uC,
and immunocomplexes were released by boiling in Laemmli
sample buffer.
Chromatin immunoprecipitation (ChIP)
Chromatin immunoprecipitations were performed essentially as
described [75] with several modifications. In brief, 2–4 hour, 4–
6 hour, 6–10 hour yw Drosophila embryos were collected, dechor-
ionated, and fixed in fixing solution (1 mM EDTA, 0.5 mM
EGTA, 100 mM NaCl, 2% formaldehyde (v/v), 50 mM HEPES,
pH 8.0) with an equal volume of n-heptane by vigorous shaking
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twice with methanol, once with storage buffer (50 mM Tris-HCl
pH 8.0, 1 mM EDTA), and kept at 280uC. Approximately
100 mL of fixed embryos were washed with 1 ml of IP buffer
(100 mM NaCl, 67 mM Tris pH 8.0, 0.33% SDS, 1.66% Triton
X-100, 5 mM EDTA) for 10 min. The following procedures were
all carried out at 4uC. Embryos were resuspended in IP buffer
containing protease inhibitor cocktail, were then sonicated
fourteen times for 12 sec by a Branson 250 sonicator at a power
setting of 4 and 30% duty cycle. After sonication, the Whole Cell
extract; (WCE) was obtained by centrifugation. 30 mL of WCE
was diluted, reverse cross-linked, and treated with proteinase K.
DNA was purified using QIAprep Spin Miniprep columns and
recovered in 100 mL of elution buffer (Qiagen) to check genomic
DNA fragments with an approximate bulk size of 300–800 bp. For
each immunoprecipitation, WCE containing 75 mg chromatin
DNA was treated with either 5 mL of nonimmune guinea pig
serum, anti-Twist antiserum (guinea pig), anti-Akirin antiserum
(rabbit), and anti-Moira antiserum (rabbit), together with 25 mLo f
protein A agarose coated with salmon sperm DNA (Upstate) for
overnight incubation. Mock immunoprecipitations were per-
formed using nonimmune guinea pig serum, preimmune rabbit
serum, and nonimmune rabbit serum. Precipitated agarose beads
were washed with mixed micelle buffer, buffer 500, LiCl/
Detergent buffer, and TE, then treated with RNase A. The
precipitated immune complexes were eluted by Bicarbonate/SDS
buffer and cross-links were reversed in the presence of proteinase
K overnight at 65uC. DNA was purified using QIAprep Spin
Miniprep columns and recovered in 200 mL of elution buffer.
Quantitative PCR was performed using the Applied Biosystems
(ABI) Prism 7700 Real-Time qPCR instrument (AQ method). One
of triplicates of reaction mixture were prepared by adding 4 ul 26
SYBR mix (usb 75762), 0.4 mL 2.5 uM Primers (Table 3), and
3.6 mL DNA template. To depict standard curves, duplicates of
each 5, 50, and 500 folds diluted DNA from WCE as described
above were used. %input and SD were calculated from triplicated
scores of immunoprecipitations over that of input WCE.
Supporting Information
Figure S1 Specificity of Akirin antibody. (A) Pre-immune serum
and anti-Akirin immunoserum were used to stain duplicate
Western blots containing wild-type whole-embryo extracts.
Volume of extract loaded is indicated above in microliters. Anti-
Akirin immunosera detects a double band of approximately 22
and 20 kDa. The same doublet is not detected with pre-immune
serum at identical concentration. Anti-a-tubulin included as a
loading control. (B) Akirin is significantly decreased in akirin
3
mutant extracts. Twenty-five (25) akirin
3 homozygous mutant and
akirin
3/+ 6–10 hr-old heterozygote embryos were loaded in each
lane, and stained with anti-Akirin antibodies. (C) Polytene
chromosomes were prepared from OregonR larvae and stained
with preimmune serum or anti-Akirin immunoserum as indicated,
at identical concentrations. Images were acquired with identical
gain and acquisition settings. Scale bar=5 mm.
(TIF)
Figure S2 Akirin protein is expressed broadly throughout the
embryo and is localized to the nucleus. (A) Hemisegment of wild-
type embryo immunostained with antibodies against Akirin and
Lamin, which labels the nuclear envelope. Scale bar=20 mm. (B)
twi-GAL4;Dmef2-GAL4.UAS-Akirin-HA embryos stained with
antibodies against HA and Twist. HA-tagged Akirin localizes to
the nucleus with Twist in these embryos. Scale bar=20 mm.
(TIF)
Figure S3 akirin mutant embryos display a range of mutant
muscle phenotypes. (A) Genomic map of akirin locus, showing
location of P-element insertions and corresponding akirin mutant
alleles used in this study. (B) Whole embryo presentations of
akirin mutant muscle phenotypes. Lateral views of stage 16 wild-
type (i, wt) and akirin mutant (ii, iii, iv) embryos demonstrate the
types of muscle phenotypes observed. All embryos stained with
anti-tropomyosin to reveal somatic musculature. All allelic
combinations are listed as maternal/paternal contribution. For
clarity, the LT muscles are used to illustrate the following
predominant muscle defects observed in akirin mutants (red
arrows): (ii) improperly attached muscles, (iii) duplicated muscles,
and (iv) missing muscles. In all figures, anterior is to left and
dorsal is up. Scale bar=50 mm. (C) akirin mRNA is maternally
loaded. RT-PCR for akirin and twist mRNA performed using
total mRNA isolated from 0–1 hour wild type embryos. Plasmid
controls provided as positive amplification controls. rp49 am-
plification included as positive control for a maternally deposited
message.
(TIF)
Figure S4 Founder cell markers appear unaffected in akirin
mutant embryos. Wild-type (wt) or akirin mutant embryos (allelic
combinations as indicated) were immunostained using antibodies
against Even-skipped (stage 11 embryos, panels A–C), Kru ¨ppel
(late stage 12, panels D–F) and Slouch (late stage 12, panels G–I).
Scale bar=50 mm.
(TIF)
Figure S5 Comparison of eveMHE-lacZ expression levels in
wild-type and akirin mutant embryos. (A) Western blot of whole
cell extracts prepared from transgenic wild-type and akirin
2
mutant embryos carrying the Dmef2-lacZ reporter. Anti-a-tubulin
staining provided as loading control. Densitometric analysis
indicates that b-galactosidase expression levels are slightly reduced
when normalized against tubulin controls (0.6 in wild-type versus
0.4 in akirin
2 mutants). (B,C) Wild type (B) and akirin
2 mutant (C)
embryos carrying a lacZ transgene under the control of the even-
skipped MHE element were stained with antibodies against b-
galactosidase. Close-up of two hemisegments presented for
comparison. No obvious difference in b-galactosidase expression
was detected in akirin mutants. Scale bar in (B,C)=20 mm.
(TIF)
Figure S6 Whole-genomic distribution of Akirin and active
transcription markers in polytene chromosomes. Shown are the
whole chromosome spreads that are referenced in Figure 4. Scale
bar=5 mm.
(TIF)
Figure S7 Ectopic overexpression of Twist in 3rd instar salivary
glands induces expression of Dmef2. Twist was expressed in
salivary glands using the Sgs3-GAL4 driver line. Expression of
Dmef2 verified by Western blotting, anti-a-tubulin provided as
loading control.
(TIF)
Figure S8 Colocalization of endogenous Akirin protein and
expressed Akirin-HA. UAS-Akirin-HA was expressed in larval
salivary glands using the Sgs3-GAL4 driver. Polytene chromo-
somes were prepared and immunostained with antibodies against
endogenous Akirin (green) and HA (red). Representative regions of
polytene squashes presented. Near-complete colocalization of
endogenous Akirin and expressed Akirin-HA was observed
(examples shown with white arrows).
(TIF)
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Brahma, (B) Snr1, and (C) Osa in polytene chromosomes. Shown
are the whole chromosome spreads referenced in Figure 5. Scale
bar=5 mm.
(TIF)
Figure S10 Heterozygous embryos for BRM complex subunit
members do not show muscle phenotypes. Stage 16 heterozygote
embryos for indicated BRM complex subunit used in Figure 6
were stained with anti-myosin antibodies to show the body wall
musculature. Heterozygous embryos were verified by immuno-
staining for marked balancers; balancer staining channel omitted
for clarity. No body wall muscle phenotypes were observed in
BRM complex subunit heterozygotes.
(TIF)
Figure S11 Twist and Brahma colocalize in the genome and
physically interact. (A) Twist was expressed in salivary glands using
the Sgs3-GAL4 driver line. Polytene chromosomes were prepared
from Twist-expressing salivary glands and immunostained with
antibodies against Twist (red) and Brahma (green). Polytene
squashes were costained with DAPI to visualize the DNA.
Colocalization between Twist and Brahma (select examples shown
in white arrows) was observed in approx. 58% of gene loci. Scale
bar=5 mm. Background staining in green channel indicated with
(*). (B) Antibodies against the Brahma core subunit successfully
immunoprecipitated Twist from wild-type (yw) embryonic ex-
tracts. ‘‘Input’’ lanes correspond to 2.5% of total embryonic
extract. Note that (B) is a composite figure; lanes were omitted
from the same gel for sake of clarity and direct comparison.
(TIF)
Figure S12 Specificity of antibodies used in chromatin immu-
noprecipitation assays. Chromatin immunoprecipitations using
antibodies against Twist, Akirin and Moira (dark blue) and
preimmune antisera (light blue, see Figure 7) were examined for
enrichment of the oskar enhancer. No enrichment of the oskar
enhancer was detected in immunoprecipitations. To enable direct
comparsion, vertical axis in (A), (B), and (C) is identical to
corresponding charts in Figure 7. For example, at 2–4 hours,
Twist enrichment at the Dmef2 versus oskar enhancers was 0.046
versus 0.0011. For Akirin, occupancy was 0.017 at the Dmef2
enhancer versus 0.00092 at oskar. For Moira, occupancy was
0.012 at the Dmef2 enhancer versus 0.00085 at oskar.
(TIF)
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